Which pharmaceutical product launch strategy pioneered the 'compassionate use' pathway that fundamentally changed how critical medications reach terminally ill patients before full FDA approval?

In the highly regulated medical industry, product launches require precise strategy and execution. Pharmaceutical and medical device companies must navigate complex regulatory approval processes, clinical trial data publication, and strategic market entry timing. This poll tests your knowledge about a significant product launch strategy that revolutionized the pharmaceutical industry's approach to bringing life-saving medications to market.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

AZT (zidovudine) for HIV/AIDS in the 1980s, which created the accelerated approval pathway for life-threatening conditions
Prozac (fluoxetine) in 1987, which introduced direct-to-consumer marketing before formal prescription availability
Lipitor (atorvastatin) in 1996, which implemented the tiered prescription access model based on patient risk profiles
Humira (adalimumab) in 2002, which created the specialty pharmacy distribution model for high-cost biologics